Nov 19, 2025 09:45AM
Aug 12, 2025 04:05PM
May 27, 2025 06:42AM
May 20, 2025 08:00AM
May 20, 2025 08:00AM
May 13, 2025 08:00AM
May 13, 2025 08:00AM ALX Oncology to Host R&D Webcast Event Highlighting its Novel EGFR Targeting Antibody-Drug Conjugate, ALX2004, on May 20, 2025
May 8, 2025 08:30AM
Apr 25, 2025 09:01AM
Apr 25, 2025 09:00AM
Apr 7, 2025 08:01AM
Apr 7, 2025 08:00AM
Mar 7, 2025 09:01AM
Mar 6, 2025 04:01PM ALX Oncology Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update
Mar 6, 2025 02:14AM
Mar 5, 2025 08:00AM
Mar 5, 2025 08:00AM
Jan 23, 2025 08:00AM
Jan 23, 2025 08:00AM
Jul 31, 2024 04:03PM
Jul 31, 2024 04:01PM ALX Oncology Reports Topline Data From ASPEN-06 Phase 2 Trial Demonstrating Evorpacept Improves Tumor Response in Patients With HER2-Positive Gastric Cancer
Aug 10, 2023 04:01PM
Jun 26, 2023 07:06AM
Jun 26, 2023 07:00AM
Mar 14, 2023 08:00AM
Mar 13, 2023 07:00AM
Mar 13, 2023 07:00AM
Jan 5, 2023 07:04AM ALX Oncology (ALXO) Provides Corporate Update
Jan 5, 2023 07:00AM
Jan 5, 2023 07:00AM
Aug 16, 2022 09:54AM
Aug 15, 2022 07:00AM
Aug 15, 2022 07:00AM
Aug 8, 2022 04:01PM
Aug 8, 2022 04:01PM ALX Oncology Reports Second Quarter 2022 Financial Results and Provides Clinical Development and Operational Highlights
Aug 1, 2022 07:00AM
Aug 1, 2022 07:00AM
Aug 1, 2022 07:00AM
Jun 29, 2022 07:01AM
Jun 29, 2022 07:00AM
Jun 29, 2022 07:00AM
Jun 3, 2022 07:05AM ALX Oncology (ALXO) Announces Evorpacept Clinical Program Updates
Jun 3, 2022 07:00AM
Jun 3, 2022 07:00AM
May 9, 2022 04:01PM
May 9, 2022 04:01PM
Feb 28, 2022 07:00AM
Feb 28, 2022 07:00AM
Jan 27, 2022 05:51PM ALX Oncology Receives U.S. FDA Orphan Drug Designation for Evorpacept for the Treatment of Patients with Gastric Cancer and Gastroesophageal Junction Cancer
Jan 27, 2022 05:51PM

322,090 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All